Adstiladrin: US approves first gene therapy for bladder cancer
The US Food and Drug Administration on Friday approved Adstiladrin, Swiss drugmaker Ferring Pharmaceuticals' first… Read More
2 years ago
bladder cancer
Blackstone to invest $400 million in gene therapy for bladder cancer
Ferring will invest $170 million in the joint venture with Blackstone, dubbed FerGene, bringing its… Read More
5 years ago